Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
18.98
-0.59 (-3.01%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pacira BioSciences Employees
As of December 31, 2023, Pacira BioSciences had 712 total employees, including 711 full-time and 1 part-time employees. The number of employees decreased by 3 or -0.42% compared to the previous year.
Employees
712
Change (1Y)
-3
Growth (1Y)
-0.42%
Revenue / Employee
$976,063
Profits / Employee
-$127,431
Market Cap
876.37M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AMN Healthcare Services | 3,585 |
Adaptive Biotechnologies | 709 |
Poseida Therapeutics | 330 |
Zymeworks | 278 |
Prothena Corporation | 173 |
Liquidia | 145 |
Nuvation Bio | 51 |
ArriVent BioPharma | 40 |
PCRX News
- 10 days ago - DOMA Perpetual Capital Management Announces Intent to Nominate Four Highly Qualified, Independent Director Candidates at 2025 Annual Meeting of Pacira BioSciences, Inc. - PRNewsWire
- 15 days ago - Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 18 days ago - Pacira Awarded New U.S. Patent Covering EXPAREL Composition - GlobeNewsWire
- 26 days ago - Pacira BioSciences: Not Done Yet Despite Devastating Share Price Losses - Seeking Alpha
- 5 weeks ago - Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee - GlobeNewsWire
- 6 weeks ago - Pacira Biosciences Inc. (PCRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Pacira BioSciences Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024 - GlobeNewsWire